Prognosis in critically ill children requiring continuous renal replacement therapy

被引:0
|
作者
Carmen Fernández
Jesús López-Herce
Jose C. Flores
Dolores Galaviz
Marta Rupérez
Kay B. Brandstrup
Amaya Bustinza
机构
[1] Gregorio Marañón Hospital,Pediatric Intensive Care Unit
[2] Sección de Cuidados Intensivos Pediátricos,undefined
来源
Pediatric Nephrology | 2005年 / 20卷
关键词
Acute renal failure; Children; Continuous venovenous hemofiltration; Renal replacement therapy; Outcome; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
We performed an observational prospective study in 53 critically ill children to analyze the prognostic factors of children requiring continuous renal replacement therapy. Pediatric index of mortality (PIM), pediatric risk of mortality score (PRISM), multi-organ failure score, serum lactate levels, blood pressure, vasoactive drugs, renal function and characteristics of renal replacement therapy were analyzed. The mortality was 32.1%, with multi-organ failure being the most frequent cause of death (59%). The children who died presented a significantly lower blood pressure and required more doses of vasoactive drugs, dopamine and epinephrine than did the survivors. The PRISM and PIM scores and the serum lactate levels and the number of organs suffering failure were significantly higher in the patients who died than in the survivors. However, the PRISM and PIM scores underestimated the risk of mortality. The age, sex, urea and creatinine levels, type of pump and volume of ultrafiltrate did not affect the prognosis. The association of a mean BP<55 mmHg and epinephrine dose >0.6 μg/kg/min was predictive of mortality in 76% of the patients. We conclude that the prognosis in children requiring renal replacement therapy depends on the severity of the clinical state at the time of starting therapy, principally on the hemodynamic situation.
引用
收藏
页码:1473 / 1477
页数:4
相关论文
共 50 条
  • [41] Clinical course of children requiring prolonged continuous renal replacement therapy
    Jesús López-Herce
    Maria J. Santiago
    Maria J. Solana
    Javier Urbano
    Jimena del Castillo
    Angel Carrillo
    Jose María Bellón
    Pediatric Nephrology, 2010, 25 : 523 - 528
  • [42] Clinical course of children requiring prolonged continuous renal replacement therapy
    Lopez-Herce, Jesus
    Santiago, Maria J.
    Solana, Maria J.
    Urbano, Javier
    del Castillo, Jimena
    Carrillo, Angel
    Maria Bellon, Jose
    PEDIATRIC NEPHROLOGY, 2010, 25 (03) : 523 - 528
  • [43] Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy
    Marshall, MR
    Golper, TA
    Shaver, MJ
    Alam, MG
    Chatoth, DK
    KIDNEY INTERNATIONAL, 2001, 60 (02) : 777 - 785
  • [44] Controversies Surrounding Renal Replacement Therapy in the Critically Ill Patient
    Iacovella, Gina M.
    Kumar, Neelja
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 40 (05) : 662 - 672
  • [45] Predicting and Managing Complications of Renal Replacement Therapy in the Critically Ill
    Selby, Nicholas M.
    McIntyre, Christopher W.
    BLOOD PURIFICATION, 2012, 34 (02) : 171 - 176
  • [46] Piperacillin population pharmacokinetics and dosing regimen optimization in critically ill children receiving continuous renal replacement therapy
    Thy, M.
    Urien, S.
    Foissac, F.
    Bouazza, N.
    Bille, E.
    Beranger, A.
    Rapp, M.
    Lui, G.
    Lesage, F.
    Renolleau, S.
    Treluyer, J. M.
    Oualha, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 76 - 76
  • [47] Meropenem population pharmacokinetics and dosing regimen optimization in critically ill children receiving continuous renal replacement therapy
    Thy, M.
    Urien, S.
    Bouazza, N.
    Foissac, F.
    Bille, E.
    Rapp, M.
    Beranger, A.
    Lui, G.
    Lesage, F.
    Renolleau, S.
    Treluyer, J. M.
    Oualha, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 92 - 93
  • [48] Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update
    Hoff, Brian M.
    Maker, Jenana H.
    Dager, William E.
    Heintz, Brett H.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (01) : 43 - 55
  • [49] Classical Indications Are Useful for Initiating Continuous Renal Replacement Therapy in Critically Ill Patients
    Lee, Jeonghwan
    Cho, Jang-Hee
    Chung, Byung Ha
    Park, Jung Tak
    Lee, Jung Pyo
    Chang, Jae Hyun
    Kim, Dong Ki
    Kim, Sejoong
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 233 (04): : 233 - 241
  • [50] Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
    Broeker, A.
    Wicha, S. G.
    Dorn, C.
    Kratzer, A.
    Schleibinger, M.
    Kees, F.
    Heininger, A.
    Kees, M. G.
    Haeberle, H.
    CRITICAL CARE, 2018, 22